Cleared Traditional

K010024 - O2/CO2 NASAL FILTERLINE

K010024 is an FDA 510(k) clearance for O2/CO2 NASAL FILTERLINE, manufactured by Oridion Medical 1987 , Ltd.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 70-day FDA review.

K010024 · Oridion Medical 1987 , Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2001
Decision
70d
Days
Class 2
Risk

K010024 is an FDA 510(k) clearance for the O2/CO2 NASAL FILTERLINE. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Oridion Medical 1987 , Ltd. (Jerusalem, IL). The FDA issued a Cleared decision on March 14, 2001 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Oridion Medical 1987 , Ltd. devices

FDA 510(k) Submission Details - K010024

510(k) Number K010024 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 2001
Decision Date March 14, 2001
Days to Decision 70 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 140d · This submission: 70d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 231
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K010024.
ORIDION MAC-LINE ORAL NASAL CANNULA SAMPLE LINE
K012394 · Oridion Medical 1987 , Ltd. · Aug 2001
MAC-LINE 02/CO2 NASAL CANNULA SAMPLE LINE
K012395 · Oridion Medical 1987 , Ltd. · Aug 2001
MICROSTREAM ORAL NASAL CANNULA FILTERLINE
K011050 · Oridion Medical 1987 , Ltd. · May 2001
INFINITY ETCO2 + RESPIRATORY MECHANICS POD
K003550 · Siemens Medical Solutions USA, Inc. · Mar 2001
MICROSTREAM EXTERNAL BATTERY CHARGER
K002163 · Oridion Medical 1987 , Ltd. · Jan 2001
CAPNO PROBE A
K984579 · Optical Sensors, Inc. · Dec 2000